Company / Income Tax
Charles River Laboratories Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$42.7M
FY2025
5-year range
$42.7M / $81.9M
FY2021-FY2025
Trend
-37.1%
vs FY2024
Sector context
#66 of 162
Health Care
What the data says
At $43M, Charles River Laboratories's income tax ranks #97 of 162 in the Health Care sector. Income Tax has fluctuated over the past 10 years, ranging from $43M in FY2025 to $171M in FY2019.
Based on SEC 10-K filings.
$43M in FY2025 with a 5-year CAGR of -4.8%.
Improved from $82M to $43M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -19.5%
- 5-Year CAGR
- -4.8%
- 10-Year CAGR
- -
Sector benchmark
#97 of 162 in Health CareTop 59% of 162This company $42.7M Sector average $145.4M
▼
-70.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -4.8%, indicating a declining trend.
- In FY2025, income tax decreased 37.1% year-over-year.
- Ranks #66 out of 162 companies in the Health Care sector.
- Peak income tax was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $42.7M | -37.1% |
| FY2024 | $67.8M | -17.2% |
| FY2023 | $81.9M | +0.1% |
| FY2022 | $81.8M | +63.5% |
| FY2021 | $50.0M | -8.2% |
| FY2020 | $54.5M | -68.2% |
| FY2019 | $171.4M | +214.7% |
| FY2018 | $54.5M | -68.2% |
| FY2017 | $171.4M | +156.4% |
| FY2016 | $66.8M | +103.1% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026